Chemical formula: C₅₂H₇₈N₁₀O₁₇ Molecular mass: 1,115.249 g/mol PubChem compound: 131704326
Inosine pranobex is a synthetic purine derivative with immunomodulatory and antiviral properties, which result from an apparent in vivo enhancement of host immune responses due to the drug.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J05AX05 | Inosine pranobex | J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AX Other antivirals |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| IMUNOVIR Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Inosine pranobex is an active ingredient of these brands:
Canada (CA)Ecuador (EC)
Ireland (IE)Lithuania (LT)
Mexico (MX)
Poland (PL)
Romania (RO)
Singapore (SG)
Turkey (TR)United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
